Lupin, HFCL and RVNL have announced key business wins, while Bosch Global Software Technologies plans an OFS in Bosch Home Comfort India. Apollo Hospi…
1/9Lupin | Lupin has launched Azilsartan Medoxomil tablets in the United States, expanding its portfolio in the cardiovascular segment. The tablet is indicated for the treatment of hypertension in adults, offering another therapeutic option for managing high blood pressure.
2/9HFCL | The company has secured an order worth ₹2,666.09 crore from Rail Vikas Nigam Limited (RVNL) for the BharatNet Phase-III project in Uttar Pradesh.
3/9Bosch Global Software Technologies is set to divest its stake in Bosch Home Comfort India Ltd through an Offer for Sale (OFS), selling up to 7.97% or 21.7 lakh shares. The offer includes a 0.75% green shoe option, with the floor price fixed at ₹1,150 per share, offering a 10% discount to the current market price.
4/9DOMS Industries | The company saw a significant block deal activity, with SBI Mutual Fund purchasing 9.3 lakh shares worth ₹205 crore and Axis Mutual Fund buying 3.6 lakh shares for ₹79.6 crore. On the other side, FILA Fabbrica Italiana sold a 7% stake, or 42.5 lakh shares, in the company for ₹935 crore. The shares were transacted at an average price of ₹2,200.33 each.
5/9RVNL | RVNL has secured an EPC order worth ₹967.92 crore from East Coast Railway.
6/9RailTel Corporation of India | RailTel received a Letter of Intent (LoI) from the Director IT for a domestic contract to develop disaster recovery IT infrastructure. Valued at ₹52.57 crore (including tax), the order involves supply, installation, integration, and commissioning at a MeitY-empanelled CSP data centre, along with operation and maintenance for five years.
7/9Apollo Hospitals Enterprises | The Reserve Bank of India (RBI) has issued a compounding order in the case of Apollo Hospitals, following which proceedings against the company have been terminated. Apollo Hospitals has paid a compounding amount of ₹17.8 crore to settle the matter.
8/9Balkrishna Industries The company has appointed Saroj Kumar Khuntia as the Chief Financial Officer of the company, effective June 18, 2026.
9/9Corona Remedies | The firm saw significant block deal activity, with Sepia Investments and Anchor Partners together selling a 7.3% stake, or 44.9 lakh shares, for ₹777 crore at an average price of ₹1,730 per share. Sepia Investments alone sold shares worth ₹749 crore, while Anchor Partners offloaded shares worth ₹28 crore. On the buying side, HDFC MF picked up 24.5 lakh shares for ₹424 crore, along with participation from Aditya Birla Sun Life MF, Aberdeen, Invesco MF, Kotak Mah MF, and WhiteOak Capital MF.
